GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $65,000 | +85.7% | 300 | 0.0% | 0.03% | +73.3% |
| Q4 2020 | $35,000 | +20.7% | 300 | 0.0% | 0.02% | +15.4% |
| Q3 2020 | $29,000 | +16.0% | 300 | +50.0% | 0.01% | +8.3% |
| Q2 2020 | $25,000 | -3.8% | 200 | -33.3% | 0.01% | -25.0% |
| Q1 2020 | $26,000 | -16.1% | 300 | 0.0% | 0.02% | +6.7% |
| Q4 2019 | $31,000 | -32.6% | 300 | -25.0% | 0.02% | -31.8% |
| Q3 2019 | $46,000 | -33.3% | 400 | 0.0% | 0.02% | -35.3% |
| Q2 2019 | $69,000 | +3.0% | 400 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $67,000 | +71.8% | 400 | 0.0% | 0.03% | +61.9% |
| Q4 2018 | $39,000 | -25.0% | 400 | +33.3% | 0.02% | -19.2% |
| Q3 2018 | $52,000 | +271.4% | 300 | +200.0% | 0.03% | +271.4% |
| Q2 2018 | $14,000 | +27.3% | 100 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $11,000 | +37.5% | 100 | +66.7% | 0.01% | +50.0% |
| Q4 2017 | $8,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |